Generate a tailored SOP for Dr. Jeremy Segal. Improve your application with a focused, well-structured draft.
Jeremy Segal is a molecular pathologist at the University of Chicago specializing in molecular pathology with a clinical focus on genomic sequencing testing for oncology diagnosis and patient management. He has expertise in the development and validation of large-scale genomic assays and bioinformatics systems that support aspects of personalized oncology practice. His research interests include genomic analysis of tumors and exploratory bioinformatics that utilizes genomics to enhance personalized cellular immunotherapy. Segal also serves as the Director of Molecular Cytogenetic Pathology and as President of the Genomics Association Academic Laboratories.
University of Chicago • Chicago, IL
Leading research and clinical programs in molecular pathology.
Department of Philosophy